test documents

PsiOxus Therapeutics named EuropaBio’s Most Innovative European Biotech SME

View

World First: The Native Antigen Company succeeds in manufacturing all four DENV NS1 serotypes from human cell lines

View

Mercia Fund Management makes first digital sector investment with Metric

View

Mercia Fund Management announces Mike Hayes as head of new digital division

View

Smart Antenna Technologies brings single antenna solution to cellular handsets

View

Antitope Announces Research Agreement with ChemomAb for Generation of Composite Human Antibodies against Inflammatory Diseases

View

Mercia Fund Management makes investment to help accelerate the growth of PolyTherics

View

Oxford Genetics secures funding for DNA cloning system

View

How Mercia Fund Management funds University of Keele spin-outs

View

PsiOxus Therapeutics initiates second clinical study of oncolytic vaccine

View